DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Davis GL, Nelson DR, Terrault N. et al.
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients
Liver Transpl 2005; 11: 941-949
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.